CD38 monoclonal antibodies
What are CD38 monoclonal antibodies?
Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards antigenic determinant on antigens and bind to form a complex which can be used for a specific purpose. CD38 monoclonal antibodies target the CD38 surface antigen of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to treat multiple myeloma.
List of CD38 monoclonal antibodies
| Drug Name | Avg. Rating | Reviews |
|---|---|---|
| daratumumab systemic (Pro) Brand name: Darzalex |
20 reviews | |
| daratumumab / hyaluronidase systemic Brand name: Darzalex Faspro |
3 reviews | |
| isatuximab systemic (Pro) Brand name: Sarclisa | No reviews | |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
See also
Medical conditions treated or associated with CD38 monoclonal antibodies:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.